EXCLUSIVE: Eucomed comes out all guns blazing as MEPs admit changes needed to reg text
This article was originally published in Clinica
Executive Summary
The European medtech industry is hopeful that Article 22, the biggest bone of contention in the EU Medical Device Regulation text that relates to how high-risk devices will be regulated in the future, could be amended and further improved. This measure, as well as 27 other compromise amendments made to the text, have been voted through by the European Parliament's committee on the environment, public health and food safety (ENVI).